Table 1.
Contrast agent partition (%) (normalized partition for CA4 +) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 h | 2 h | 24 h | 48 h | 72 h | ||||||||
Location | CA4+ | Gadoteridol | CA4+ | Gadoteridol | CA4+ | Gadoteridol | CA4+ | Gadoteridol | CA4+ | Gadoteridol | Optical density | Mankin score |
FLC | 110 ± 20 | 44 ± 8 | 142 ± 15 | 51 ± 6 | 324 ± 61 | 64 ± 3 | 386 ± 76 | 66 ± 7 | 422 ± 84 | 67 ± 5 | 0.85 ± 0.19 | 4.86 ± 2.14 |
(n = 8) | (261 ± 74) | (289 ± 51) | (511 ± 112) | (602 ± 162) | (649 ± 172) | |||||||
FMC | 120 ± 16 | 46 ± 10 | 152 ± 23 | 53 ± 9 | 376 ± 49 | 60 ± 6 | 428 ± 63 | 65 ± 4 | 439 ± 77 | 69 ± 8 | 0.87 ± 0.07 | 6.45 ± 1.99 |
(n = 7) | (292 ± 81) | (302 ± 79) | (642 ± 98) | (671 ± 109) | (652 ± 176) | |||||||
FT | 122 ± 18 | 42 ± 8 | 150 ± 12 | 53 ± 7 | 368 ± 62 | 61 ± 4 | 426 ± 108 | 62 ± 4 | 452 ± 113 | 63 ± 4 | 0.89 ± 0.20 | 4.96 ± 1.08 |
(n = 6) | (313 ± 90) | (289 ± 50) | (615 ± 136) | (709 ± 225) | (729 ± 189) | |||||||
TLC | 105 ± 29 | 43 ± 13 | 141 ± 33 | 50 ± 9 | 320 ± 60 | 65 ± 6 | 398 ± 88 | 65 ± 5 | 429 ± 91 | 65 ± 4 | 0.81 ± 0.21 | 5.77 ± 1.78 |
(n = 12) | (247 ± 79) | (290 ± 80) | (506 ± 120) | (639 ± 188) | (672 ± 155) | |||||||
TMC | 112 ± 37 | 44 ± 4 | 142 ± 39 | 53 ± 8 | 353 ± 85 | 62 ± 7 | 426 ± 87 | 63 ± 7 | 464 ± 91 | 62 ± 6 | 0.87 ± 0.15 | 6.62 ± 1.14 |
(n = 12) | (245 ± 93) | (273 ± 83) | (599 ± 222) | (700 ± 201) | (764 ± 176) | |||||||
Total | 112 ± 28 | 44 ± 9 | 144 ± 29 | 52 ± 8 | 345 ± 70 | 63 ± 6 | 412 ± 87 | 64 ± 6 | 442 ± 93 | 65 ± 6 | 0.85 ± 0.18 | 5.83 ± 1.81 |
(n = 45) | (265 ± 88) | (287 ± 73) | (567 ± 162) | (663 ± 187) | (697 ± 178) |
FLC, femoral lateral condyle; FMC, femoral medial condyle; FT, femoral trochlea; TLC, tibial lateral condyle; TMC, tibial medial condyle.